Baird, Pritzker back health care startup Apervita in $18M Series A

Written by
Published on Jan. 10, 2015
[ibimage==43527==Original==none==self==ibimage_align-center]
 
Health analytics marketplace Apervita has completed an $18 million Series A round of funding this week. The round was led GE Ventures and Baird Capital, with participation from Pritzker Group Venture Capital, Math Ventures and existing investors.
 
Apervita will use the funding to continue development of its platform and grow their sales and marketing team. 
 
“Apervita facilitates the capture and diffusion of health insight by making it easier than ever to author, connect and collaborate. The Apervita self-service platform enables authors to share their evidence-based research as computable insights and publish them to a marketplace, allowing users to subscribe, and connect them to their workflow,” Paul Magelli, founder and CEO of Apervita, said in a statement. “Apervita faces unprecedented demand, and this investment will accelerate our mission to empower the world’s leading community of health professionals to solve thousands of global challenges by connecting their trusted knowledge to practice.”
 
Health professionals using Apervita have access to analytics through its secure and HIPAA–compliant cloud platform. Users can connect health datasets and share and publish insights to a marketplace of health analytics.
 
“By combining marketplace economics, cloud computing and light-touch streaming implementation, Apervita will fundamentally change the way healthcare is delivered,” Noah Lewis, managing director of healthcare at GE Ventures, said in a statement. “Their innovative business model aligns perfectly with our vision for data-driven, predictive healthcare, and we look forward to helping them scale through this next stage of expansion.”
 
Have a tip for us or know of a company that deserves coverage? Email us via [email protected]
 
Hiring Now
Moov Financial
Fintech • Payments